foreign places Doctors Foster and Smith Benzocaine Liquid Generic Name: benzocaine liquid Dosage Form: FOR ANIMAL USE ONLY Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Drs. Foster and Smith CutStop styptic pads have been specially formulated as an aid in the control of minor bleeding. CutStop will also serve to temporarily relieve pain caused by clipping nails or small wounds. DIRECTIONS FOR USE Apply pad directly to bleeding area with slight pressure. If bleeding persists, or in the case of a puncture wound, consult a veterinarian immediately. ACTIVE INGREDIENT 0.2% Benzocaine OTHER INGREDIENTS Water, Ferric Subsulfate, Isopropyl Alcohol, Benzalkonium Chloride. Item#1086 For questions or to reorder: 1-800-562-7169 www.DrsFosterSmith.com Keep out of reach of children and pets to avoid unwanted consumption Doctors Foster and Smith CUTSTOP Ready - to -Use Styptic pads Stops bleeding from clipped nails or small wounds 90 Pads DOCTORS FOSTER AND SMITH benzocaine liquid Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:65713-911 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BENZOCAINE (BENZOCAINE) BENZOCAINE 0.207 g in 103.6 g Inactive Ingredients Ingredient Name Strength WATER FERRIC SULFATE ISOPROPYL ALCOHOL BENZALKONIUM CHLORIDE Packaging # Item Code Package Description 1 NDC:65713-911-05 103.6 g in 1 JAR Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2001 Labeler - Doctors Foster and Smith (122135148) Registrant - United Pet Group (931135730) Establishment Name Address ID/FEI Operations JUNGLE LABORATORIES CORPORATION 032615270 manufacture Revised: 02/2010 Doctors Foster and Smith FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More fees
any person Doctors Foster and Smith Benzocaine Liquid outcome
EmoticonEmoticon